EP 623 : OpenAI’s AI Intern Breakthrough, Insilico’s Anti‑Aging Drug & US Voter AI Fear

<p>Ever wondered how far behind the rest of the world you are when OpenAI’s internal AI agents start out‑producing human researchers? In this episode we peel back the curtain on OpenAI’s newly published research intern report, revealing that coding agents now log 3.1 workdays for every human day, that 80 % of researchers juggle four or more agents simultaneously, and that token spending has exploded to over $600 per day per researcher. We discuss why this “internal use advantage” could widen the gap between frontier labs and every other AI team.Next, we shift to biotech. Insilico Medicine’s AI‑designed molecule rentosertib, originally aimed at idiopathic pulmonary fibrosis, showed a surprising side‑effect: participants looked biologically younger on six independent aging clocks. We break down the trial, the magnitude of the age‑reversal signal, and why a breakthrough like this could reshape public sentiment about AI‑driven medicine.We then dive into the political pulse. A fresh NBC News poll of more than 7,000 U.S. adults shows AI fear is the rare bipartisan issue, with 70 % of voters more worried than excited and a majority distrusting both parties to regulate the technology. We explore what this means for upcoming midterms, data‑center siting battles, and the broader narrative around AI’s impact on jobs, schools and elections.Finally, we skim today’s AI headlines—EcoGPT’s green‑scam hype, OpenAI’s new “ChatGPT Work” writing‑assistant, ByteDance’s secret world‑model project, and the latest lawsuit targeting OpenAI and Microsoft. We close with a roundup of the most useful AI tools you can start using right now to boost productivity.🔧 Tools mentioned: Tables, Dictantor, GoodLads, MiniCPM5‑2B, Grok Bot Marketplace, Gemini 3.8 Flash, Muse Voice Transcribe.</p>